Anna Di Benedetto
Istituti di Ricovero e Cura a Carattere Scientifico(IT)
Publications by Year
Research Areas
HER2/EGFR in Cancer Research, Hippo pathway signaling and YAP/TAZ, Male Breast Health Studies, Cancer-related Molecular Pathways, Cancer and Skin Lesions
Most-Cited Works
- → TAZ is required for metastatic activity and chemoresistance of breast cancer stem cells(2014)360 cited
- → miR-204 targets Bcl-2 expression and enhances responsiveness of gastric cancer(2012)180 cited
- → A comparative biomarker study of 514 matched cases of male and female breast cancer reveals gender-specific biological differences(2011)130 cited
- → Type I IFNs promote cancer cell stemness by triggering the epigenetic regulator KDM1B(2022)112 cited
- → A divergent role for estrogen receptor-beta in node-positive and node-negative breast cancer classified according to molecular subtypes: an observational prospective study(2008)107 cited
- → Direct regulation of microRNA biogenesis and expression by estrogen receptor beta in hormone-responsive breast cancer(2012)99 cited
- → HER2 Protein and Gene Variation between Primary and Metastatic Breast Cancer: Significance and Impact on Patient Care(2011)98 cited
- → miR‐10b*, a master inhibitor of the cell cycle, is down‐regulated in human breast tumours(2012)95 cited
- → High-mobility group A1 inhibits p53 by cytoplasmic relocalization of its proapoptotic activator HIPK2(2007)90 cited
- → The Cytoskeleton Regulatory Protein hMena (ENAH) Is Overexpressed in Human Benign Breast Lesions with High Risk of Transformation and Human Epidermal Growth Factor Receptor-2–Positive/Hormonal Receptor–Negative Tumors(2006)87 cited